- Home
- CBOE vs GEHC Comparison
CBOE vs GEHC Comparison
Compare CBOE & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CBOE | GEHC |
|---|---|---|
| Founded | 1973 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Computer Software: Prepackaged Software |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.5B | 29.1B |
| IPO Year | 2010 | 2022 |
Fundamental Metrics
Financial Performance| Metric | CBOE | GEHC |
|---|---|---|
| Price | $304.08 | $65.60 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 18 | 21 |
| Target Price | ★ $320.47 | $82.90 |
| AVG Volume (30 Days) | 1.1M | ★ 3.3M |
| Earning Date | 10-30-2026 | 10-28-2026 |
| Dividend Yield | ★ 1.17% | 0.25% |
| EPS Growth | ★ 44.52 | 4.84 |
| EPS | ★ 7.01 | 0.85 |
| Revenue | $2,229,100,000.00 | ★ $20,625,000,000.00 |
| Revenue This Year | N/A | $5.33 |
| Revenue Next Year | $3.13 | $4.60 |
| P/E Ratio | ★ $41.95 | $75.55 |
| Revenue Growth | ★ 239.31 | 4.84 |
| 52 Week Low | $227.15 | $58.75 |
| 52 Week High | $371.18 | $89.77 |
Technical Indicators
Market Signals| Indicator | CBOE | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 65.59 | 47.88 |
| Support Level | $273.63 | $60.14 |
| Resistance Level | $307.94 | $66.04 |
| Average True Range (ATR) | 11.09 | 1.33 |
| MACD | 4.45 | 0.13 |
| Stochastic Oscillator | 94.64 | 60.90 |
Price Performance
Historical ComparisonAbout CBOE Cboe Global Markets Inc.
Founded in 1973, Cboe controls the largest option exchange in the US, which provides around 60% of the firm's revenue. The company is best known for its proprietary S&P 500 and VIX index options, which it offers through an exclusive contract with S&P Global. The firm moved into US and European equities through the $3.4 billion acquisition of BATS in 2017. Cboe has continued to look to expand internationally, using acquisitions to build a presence in both Canada and Australia.
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).